A new AI framework estimates how cells change over time and infers the gene regulatory networks controlling those changes.

EnGene (NASDAQ: ENGN) stock suffered a more-than-80% plunge this past week that reflects just how competitive the field is ...

A study in mice showed how T2D drug metformin exerts multiple clinical effects through selective inhibition of mitochondrial ...

There is no margin for error in the pharma and biopharma sectors. If the chain-identity breaks anywhere along the way, there ...

For the second year in a row, GEN spoke with David Barrett, JD, who has been the CEO of ASGCT since 2016. In this interview, ...

At ASGCT, the company will share data showing that its RNA achieves higher, more durable protein expression compared to other ...

The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene ...

Enein, MD, PhD, for a measurement-driven approach that advances cell therapy translation, from high-dimensional analytics to ...

Macrophages use cell‑volume changes to sense danger, reprogram gene expression, and heighten inflammatory and antiviral responses.

Vyriad officials say that the company's G-Link platform can address some of the most persistent challenges in in vivo delivery.

Researchers say identified mAbs could represent “a basis to develop a treatment that is urgently needed as measles virus ...